AU2018901386A0 - Gemcitabine Amphiphile prodrugs - Google Patents

Gemcitabine Amphiphile prodrugs

Info

Publication number
AU2018901386A0
AU2018901386A0 AU2018901386A AU2018901386A AU2018901386A0 AU 2018901386 A0 AU2018901386 A0 AU 2018901386A0 AU 2018901386 A AU2018901386 A AU 2018901386A AU 2018901386 A AU2018901386 A AU 2018901386A AU 2018901386 A0 AU2018901386 A0 AU 2018901386A0
Authority
AU
Australia
Prior art keywords
amphiphile
gemcitabine
prodrugs
gemcitabine amphiphile
amphiphile prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018901386A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanomed Holdings Pty Ltd
Original Assignee
Nanomed Holdings Pty Ltd
Filing date
Publication date
Application filed by Nanomed Holdings Pty Ltd filed Critical Nanomed Holdings Pty Ltd
Publication of AU2018901386A0 publication Critical patent/AU2018901386A0/en
Priority to PCT/AU2019/050363 priority Critical patent/WO2019204869A1/en
Priority to JP2021508032A priority patent/JP2021522331A/en
Priority to EP19792914.4A priority patent/EP3784681A4/en
Priority to US17/050,160 priority patent/US20210238214A1/en
Priority to AU2019258590A priority patent/AU2019258590B2/en
Priority to CN201980042896.0A priority patent/CN113166189A/en
Abandoned legal-status Critical Current

Links

AU2018901386A 2018-04-26 2018-04-26 Gemcitabine Amphiphile prodrugs Abandoned AU2018901386A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/AU2019/050363 WO2019204869A1 (en) 2018-04-26 2019-04-24 Gemcitabine amphiphile prodrugs
JP2021508032A JP2021522331A (en) 2018-04-26 2019-04-24 Gemcitabine amphipathic prodrug
EP19792914.4A EP3784681A4 (en) 2018-04-26 2019-04-24 Gemcitabine amphiphile prodrugs
US17/050,160 US20210238214A1 (en) 2018-04-26 2019-04-24 Gemcitabine amphiphile prodrugs
AU2019258590A AU2019258590B2 (en) 2018-04-26 2019-04-24 Gemcitabine amphiphile prodrugs
CN201980042896.0A CN113166189A (en) 2018-04-26 2019-04-24 Gemcitabine amphiphilic prodrugs

Publications (1)

Publication Number Publication Date
AU2018901386A0 true AU2018901386A0 (en) 2018-05-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP3803740A4 (en) Blockchain overwatch
EP3801265A4 (en) Uroflowmeter
EP3294287A4 (en) Oxabicycloheptane prodrugs
EP3784463A4 (en) Fluorosulfones
EP4053471A4 (en) Electrocaloric effect element
EP3479227A4 (en) Correlating multiple sources
EP3786170A4 (en) Novel plasmalogen derivative
EP3721129A4 (en) Cryosphere
EP3810622A4 (en) Platinum-based amphiphile prodrugs
EP3784681A4 (en) Gemcitabine amphiphile prodrugs
EP3820879A4 (en) Phosphorus-containing prodrugs of gemcitabine
EP3885347A4 (en) Dihydropyrrolopyrazole derivative
EP3770162A4 (en) Dihydrochromene derivative
EP3741757A4 (en) Dihydroindolizinone derivative
AU2018901386A0 (en) Gemcitabine Amphiphile prodrugs
AU2018901352A0 (en) Gemcitabine Amphiphile prodrugs
EP3738602A4 (en) Cytocide
EP3573994A4 (en) Cysteamine prodrugs
AU2018902222A0 (en) Platinum-based amphiphile prodrugs
EP3872061A4 (en) 1-phenyl-2-phenylethane derivative
EP4055567A4 (en) Arbitrary view generation
AU2018101027A4 (en) PadPay
EP3851522A4 (en) Pacas9 nuclease
GB201808537D0 (en) Prodrugs
EP3813839A4 (en) Metabolically stable prodrugs